246 related articles for article (PubMed ID: 32870918)
1. Pharmacologic and surgical therapies for patients with Meniere's disease: A systematic review and network meta-analysis.
Ahmadzai N; Cheng W; Kilty S; Esmaeilisaraji L; Wolfe D; Bonaparte J; Schramm D; Fitzpatrick E; Lin V; Skidmore B; Hutton B
PLoS One; 2020; 15(9):e0237523. PubMed ID: 32870918
[TBL] [Abstract][Full Text] [Related]
2. Pharmacologic and surgical therapies for patients with Meniere's disease: a protocol for a systematic review and meta-analysis.
Ahmadzai N; Cheng W; Wolfe D; Bonaparte J; Schramm D; Fitzpatrick E; Lin V; Skidmore B; Esmaeilisaraji L; Kilty S; Hutton B
Syst Rev; 2019 Dec; 8(1):341. PubMed ID: 31888735
[TBL] [Abstract][Full Text] [Related]
3. Positive pressure therapy for Ménière's disease or syndrome.
van Sonsbeek S; Pullens B; van Benthem PP
Cochrane Database Syst Rev; 2015 Mar; 2015(3):CD008419. PubMed ID: 25756795
[TBL] [Abstract][Full Text] [Related]
4. Intratympanic gentamicin for Ménière's disease.
Webster KE; Galbraith K; Lee A; Harrington-Benton NA; Judd O; Kaski D; Maarsingh OR; MacKeith S; Ray J; Van Vugt VA; Burton MJ
Cochrane Database Syst Rev; 2023 Feb; 2(2):CD015246. PubMed ID: 36847592
[TBL] [Abstract][Full Text] [Related]
5. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
[TBL] [Abstract][Full Text] [Related]
6. Outcomes of endolymphatic shunt surgery for Ménière's disease: comparison with intratympanic gentamicin on vertigo control and hearing loss.
Derebery MJ; Fisher LM; Berliner K; Chung J; Green K
Otol Neurotol; 2010 Jun; 31(4):649-55. PubMed ID: 20431498
[TBL] [Abstract][Full Text] [Related]
7. Systemic pharmacological interventions for Ménière's disease.
Webster KE; Galbraith K; Harrington-Benton NA; Judd O; Kaski D; Maarsingh OR; MacKeith S; Ray J; Van Vugt VA; Burton MJ
Cochrane Database Syst Rev; 2023 Feb; 2(2):CD015171. PubMed ID: 36827524
[TBL] [Abstract][Full Text] [Related]
8. A systematic review and network meta-analysis of existing pharmacologic therapies in patients with idiopathic sudden sensorineural hearing loss.
Ahmadzai N; Kilty S; Cheng W; Esmaeilisaraji L; Wolfe D; Bonaparte JP; Schramm D; Fitzpatrick E; Lin V; Skidmore B; Moher D; Hutton B
PLoS One; 2019; 14(9):e0221713. PubMed ID: 31498809
[TBL] [Abstract][Full Text] [Related]
9. Betahistine in Ménière's Disease or Syndrome: A Systematic Review.
Van Esch B; van der Zaag-Loonen H; Bruintjes T; van Benthem PP
Audiol Neurootol; 2022; 27(1):1-33. PubMed ID: 34233329
[TBL] [Abstract][Full Text] [Related]
10. Surgical interventions for Ménière's disease.
Lee A; Webster KE; George B; Harrington-Benton NA; Judd O; Kaski D; Maarsingh OR; MacKeith S; Ray J; Van Vugt VA; Burton MJ
Cochrane Database Syst Rev; 2023 Feb; 2(2):CD015249. PubMed ID: 36825750
[TBL] [Abstract][Full Text] [Related]
11. Intratympanic corticosteroids for Ménière's disease.
Webster KE; Lee A; Galbraith K; Harrington-Benton NA; Judd O; Kaski D; Maarsingh OR; MacKeith S; Ray J; Van Vugt VA; Westerberg B; Burton MJ
Cochrane Database Syst Rev; 2023 Feb; 2(2):CD015245. PubMed ID: 36847608
[TBL] [Abstract][Full Text] [Related]
12. Betahistine for Menière's disease or syndrome.
James AL; Burton MJ
Cochrane Database Syst Rev; 2001; 2001(1):CD001873. PubMed ID: 11279734
[TBL] [Abstract][Full Text] [Related]
13. Intratympanic gentamicin therapy for Ménière's disease: a meta-analysis.
Chia SH; Gamst AC; Anderson JP; Harris JP
Otol Neurotol; 2004 Jul; 25(4):544-52. PubMed ID: 15241234
[TBL] [Abstract][Full Text] [Related]
14. Endolymphatic duct blockage: a randomized controlled trial of a novel surgical technique for Ménière's disease treatment.
Saliba I; Gabra N; Alzahrani M; Berbiche D
Otolaryngol Head Neck Surg; 2015 Jan; 152(1):122-9. PubMed ID: 25403881
[TBL] [Abstract][Full Text] [Related]
15. Long-term hearing outcome in patients receiving intratympanic gentamicin for Ménière's disease.
Wu IC; Minor LB
Laryngoscope; 2003 May; 113(5):815-20. PubMed ID: 12792316
[TBL] [Abstract][Full Text] [Related]
16. Effectiveness of intratympanic dexamethasone for the treatment of vertigo attacks in patients with Ménière's disease compared with betahistine pharmacotherapy.
Molnár A; Maihoub S; Tamás L; Szirmai Á
J Int Med Res; 2021 Apr; 49(4):300060520985647. PubMed ID: 33845616
[TBL] [Abstract][Full Text] [Related]
17. Intratympanic steroid versus gentamicin for treatment of refractory Meniere's disease: A meta-analysis.
Lee SY; Kim YS; Jeong B; Carandang M; Koo JW; Oh SH; Lee JH
Am J Otolaryngol; 2021; 42(6):103086. PubMed ID: 34098455
[TBL] [Abstract][Full Text] [Related]
18. Interventions for Menière's disease: an umbrella systematic review.
van Esch BF; van der Zaag-Loonen H; Bruintjes T; Kuijpers T; van Benthem PPG
BMJ Evid Based Med; 2022 Aug; 27(4):235-245. PubMed ID: 34750154
[TBL] [Abstract][Full Text] [Related]
19. What is the efficacy of gentamicin on the incidence of vertigo attacks and hearing in patients with Meniere's disease compared with steroids? A meta-analysis.
Jiang M; Zhang Z; Zhao C
J Neurol; 2021 Oct; 268(10):3717-3727. PubMed ID: 32588183
[TBL] [Abstract][Full Text] [Related]
20. Intratympanic gentamicin for Ménière's disease or syndrome.
Pullens B; van Benthem PP
Cochrane Database Syst Rev; 2011 Mar; (3):CD008234. PubMed ID: 21412917
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
